Results 171 to 180 of about 30,099 (284)

Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection

, 2009
Christine Katlama
openalex   +2 more sources

Fragment-Based Discovery of 8-Hydroxyquinoline Inhibitors of the HIV-1 Integrase–Lens Epithelium-Derived Growth Factor/p75 (IN–LEDGF/p75) Interaction

, 2013
Erik Serrao, Bikash Debnath, Hiroyuki Otake, Yuting Kuang, Frauke Christ, Zeger Debyser, Nouri Neamati   +6 more
openalex   +2 more sources

Non-Nucleoside Reverse Transcriptase Inhibitors Join Forces with Integrase Inhibitors to Combat HIV [PDF]

, 2020
D.M. Himmel, Eddy Arnold
openalex   +1 more source

Systematic determination of in vitro phenotypic resistance to HIV-1 integrase strand transfer inhibitors from clinical samples [PDF]

, 2019
Aniqa Shahid, Wendy W. Zhang, Vincent Montoya, Peter K. Cheung, Natália Oliveira, Manraj S. Sidhu, Conan K. Woods, Marjorie Robbins, Chanson J. Brumme, P. Richard Harrigan   +9 more
openalex   +1 more source

Structural Comparison of Diverse HIV-1 Subtypes using Molecular Modelling and Docking Analyses of Integrase Inhibitors [PDF]

, 2020
Darren Isaacs, Sello Given Mikasi, Adetayo Emmanuel Obasa, George Mondinde Ikomey, Sergey Shityakov, Ruben Cloete, Graeme Brendon Jacobs   +6 more
openalex   +1 more source

A Substituted Indole Scaffold as a Class of Allosteric HIV-1 Integrase Inhibitor

, 2019
Ross H. Bockbrader
openalex   +1 more source

Carbamoyl Pyridone HIV-1 Integrase Inhibitors 3. A Diastereomeric Approach to Chiral Nonracemic Tricyclic Ring Systems and the Discovery of Dolutegravir (S/GSK1349572) and (S/GSK1265744)

, 2013
Brian A. Johns, Takashi Kawasuji, Jason G. Weatherhead, Teruhiko Taishi, David P. Temelkoff, Hiroshi Yoshida, Toshiyuki Akiyama, Yoshiyuki Taoda, Hitoshi Murai, Ryuichi Kiyama, Masahiro Fuji, Norihiko Tánimoto, Jerry Jeffrey, Scott A. Foster, Tomokazu Yoshinaga, Takahiro Seki, Masanori Kobayashi, Akihiko Sato, Matthew N. Johnson, Edward P. Garvey, Tamio Fujiwara   +20 more
openalex   +1 more source

Repurposing FDA-approved drugs as HIV-1 integrase inhibitors: an in silico investigation

, 2022
Christopher Heng Xuan Ha, Nung Kion Lee, Taufiq Rahman, Siaw San Hwang, Wai Keat Yam, Chee, Xavier Wezen   +5 more
openalex   +1 more source

HIV-1 drug resistance and associated risk factors in patients with antiretroviral therapy failure in Chongqing, China, 2019-2023. [PDF]

PLoS One
Zhang H, Wu P, Ye W.
europepmc   +1 more source

Targeting Integration beyond Strand Transfer: Development of Second‐Generation HIV Integrase Inhibitors

, 2011
Arnout Voet, Marc De Maeyer, Frauke Christ, Zeger Debyser   +3 more
openalex   +2 more sources